Allopurinol, gout, and cardiovascular risk - Top-Institutions - MDSpire

Allopurinol, gout, and cardiovascular risk

  • By

  • Jalina Jannink

  • Arend Mosterd

  • Aernoud T L Fiolet

  • October 29, 2025

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Brigham and Women's Hospital
    Brigham and Women's Hospital

    Boston, MA

    Key Differentiators

    • Rheumatology
    • Cardiology
    • Clinical Pharmacology

  • #2

    University of Oxford
    University of Oxford

    Oxford, England

    Key Differentiators

    • Epidemiology
    • Rheumatology
    • Cardiovascular Medicine

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Rheumatology
    • Cardiology

  • #4

    University of Amsterdam
    University of Amsterdam

    Amsterdam, Netherlands

    Key Differentiators

    • Pharmaco-epidemiology
    • Rheumatology

Original Source(s)

Allopurinol, gout, and cardiovascular risk

  • by Jalina Jannink, Arend Mosterd, Aernoud T L Fiolet

  • October 29, 2025

Related Content

10 CMS and FDA Actions Affecting Care in 2026

From Medicare payment updates to drug approvals and device access, these federal actions may affect reimbursement, prescribing, patient access, and clinical workflows.

Stroke Audit Finds Long CT-to-CTA Times

A regional UK audit found wide variation in imaging intervals among patients referred for mechanical thrombectomy and identified potentially modifiable barriers to timely vascular imaging.

Linking glucose metabolism to arterial stiffness and blood pressure in non-diabetic adults: the mediating role of FGF21